NanoRepro AG (NN6) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NanoRepro AG (NN6) has a cash flow conversion efficiency ratio of 0.055x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.05 Million ≈ $2.40 Million USD) by net assets (€37.30 Million ≈ $43.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NanoRepro AG stock valuation for the company's overall valuation and market capitalisation.
NanoRepro AG - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how NanoRepro AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
NanoRepro AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NanoRepro AG ranked by their cash flow conversion efficiency. Explore NN6 cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Key Tronic Corporation
NASDAQ:KTCC
|
-0.039x |
|
Vietnam Petroleum Transport JSC
VN:VIP
|
-0.030x |
|
Interhides Public Company Limited
BK:IHL
|
0.018x |
|
Agroton Public Ltd.
WAR:AGT
|
-0.142x |
|
Geomega Resources Inc
V:GMA
|
-0.797x |
|
GEE Group Inc
NYSE MKT:JOB
|
-0.024x |
|
A SPAC III Acquisition Corp. Class A Ordinary Shares
NASDAQ:ASPC
|
-0.056x |
|
Seoyon Topmetal Co. Ltd
KQ:019770
|
0.081x |
Annual Cash Flow Conversion Efficiency for NanoRepro AG (2013–2024)
The table below shows the annual cash flow conversion efficiency of NanoRepro AG from 2013 to 2024. View NanoRepro AG (NN6) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €38.14 Million ≈ $44.59 Million |
€9.86 Million ≈ $11.53 Million |
0.259x | +201.70% |
| 2023-12-31 | €40.38 Million ≈ $47.20 Million |
€-10.26 Million ≈ $-12.00 Million |
-0.254x | -191.73% |
| 2022-12-31 | €47.43 Million ≈ $55.45 Million |
€13.14 Million ≈ $15.37 Million |
0.277x | +95.60% |
| 2021-12-31 | €57.61 Million ≈ $67.35 Million |
€8.16 Million ≈ $9.54 Million |
0.142x | +200.82% |
| 2020-12-31 | €7.99 Million ≈ $9.34 Million |
€-1.12 Million ≈ $-1.31 Million |
-0.141x | -1.63% |
| 2019-12-31 | €4.43 Million ≈ $5.18 Million |
€-612.40K ≈ $-715.96K |
-0.138x | -201.53% |
| 2018-12-31 | €5.62 Million ≈ $6.57 Million |
€-257.60K ≈ $-301.16K |
-0.046x | +84.68% |
| 2017-12-31 | €3.82 Million ≈ $4.47 Million |
€-1.14 Million ≈ $-1.34 Million |
-0.299x | -18.04% |
| 2016-12-31 | €3.03 Million ≈ $3.55 Million |
€-769.70K ≈ $-899.86K |
-0.254x | +38.28% |
| 2015-12-31 | €2.27 Million ≈ $2.66 Million |
€-934.60K ≈ $-1.09 Million |
-0.411x | -43.01% |
| 2014-12-31 | €1.91 Million ≈ $2.23 Million |
€-548.00K ≈ $-640.67K |
-0.287x | +39.65% |
| 2013-12-31 | €1.64 Million ≈ $1.92 Million |
€-783.00K ≈ $-915.41K |
-0.476x | -- |
About NanoRepro AG
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. It offers rapid diagnostic tests, such as family planning, and preve… Read more